Table 2. Baseline and postbiopsy International Index Erectile Function-5 Score.
| N at pre-TPSBx | N at one month post-TPSBx | N at three months post-TPSBx | N at six months post-TPSBx | |
|---|---|---|---|---|
| First TP | ||||
| Without ED (IIEF-5 22–25) | 29 (45.3%) | 0 | 20 (31.3%) | 29 (45.3%) |
| Mild ED (IIEF-5 17–21) | 23 (35.9%) | 12 (18.8%) | 29 (45.3%) | 23 (35.9%) |
| Mild/Moderate ED (IIEF-5 12–16) | 3 (4.7%) | 9 (14.1%) | 5 (7.8%) | 4 (6.3%) |
| Moderate ED (IIEF-5 8–11) | 5 (7.8%) | 23 (35.9%) | 7 (10.9%) | 6 (9.4%) |
| Severe ED (IIEF-5 1–7) | 2 (3.1%) | 18 (28.1%) | 0 | 0 |
| No sexual function (IIEF-5 0) | 2 (3.1%) | 2 (3.1%) | 2 (3.1%) | 2 (3.1%) |
| Missing | 0 | 0 | 1 (1.6%) | 0 |
| Second TP | ||||
| Without ED (IIEF-5 22–25) | 13 (20.3%) | 3 (4.7%) | 5 (7.8%) | 12 (18.7%) |
| Mild ED (IIEF-5 17–21) | 27 (42.2%) | 5 (7.8%) | 25 (39.1%) | 24 (37.5%) |
| Mild/Moderate ED (IIEF-5 12–16) | 11 (17.2%) | 9 (14.1%) | 12 (18.8%) | 11 (17.2%) |
| Moderate ED (IIEF-5 8–11) | 5 (7.8%) | 7 (10.9%) | 4 (6.2%) | 8 (12.5%) |
| Severe ED (IIEF-5 1–7) | 3 (4.7%) | 25 (39.1%) | 4 (6.2%) | 1 (1.6%) |
| No sexual function (IIEF-5 0) | 5 (7.8%) | 15 (23.4%) | 9 (14.1%) | 8 (12.5%) |
| Missing | 0 | 0 | 5 (7.8%) | 0 |